878570799	878570799	CD	B-NP	O
|	|	NN	I-NP	O
VC	VC	NN	I-NP	O
|	|	NN	I-NP	O
87322051	87322051	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3512149	3512149	CD	B-NP	O
|	|	CC	I-NP	O
10/9/2004	10/9/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Congestive	Congestive	JJ	I-NP	I-protein
heart	heart	NN	I-NP	I-protein
failure	failure	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/17/2004	1/17/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/3/2004	9/3/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	B-protein
CURBO	CURBO	NNP	B-NP	I-protein
,	,	,	O	O
IVAN	IVAN	NNP	B-NP	O
C	C	NNP	I-NP	O
364-17-17-6	364-17-17-6	CD	I-NP	O
Dence	Dence	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/21/04	1/21/04	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
COUDRIET	COUDRIET	NNP	B-NP	O
,	,	,	O	O
JESUS	JESUS	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
PETRICH	PETRICH	NNP	B-NP	O
,	,	,	O	O
CHI	CHI	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

SERIOUS	SERIOUS	JJ	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
METROGEL	METROGEL	NN	I-NP	O
0.75	0.75	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METRONIDAZOLE	METRONIDAZOLE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
area	area	NN	I-NP	O
per	per	IN	B-PP	O
wife/pt	wife/pt	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
REEKERS	REEKERS	NNP	B-NP	O
,	,	,	O	O
RUFUS	RUFUS	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

SERIOUS	SERIOUS	JJ	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
METRONIDAZOLE	METRONIDAZOLE	NNP	I-NP	O
,	,	,	O	O
TOPICAL	TOPICAL	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
Taper	Taper	NN	I-NP	O
PO	PO	NN	I-NP	O
Give	Give	VB	B-VP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Give	Give	VB	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Starting	Start	VBG	B-VP	O
ON	ON	NN	B-NP	B-DNA
3/5/04	3/5/04	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	O
2/15	2/15	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
METAMUCIL	METAMUCIL	NNP	I-NP	O
SUGAR	SUGAR	NNP	I-NP	O
FREE	FREE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PSYLLIUM	PSYLLIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METAMUCIL	METAMUCIL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SU	SU	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
PACKET	PACKET	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
TERAZOSIN	TERAZOSIN	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
TRAZODONE	TRAZODONE	NN	I-NP	O
50	50	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/25	8/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
SANSBURY	SANSBURY	NNP	B-NP	O
,	,	,	O	O
LAZARO	LAZARO	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
METROGEL	METROGEL	NN	B-NP	O
0.75	0.75	CD	I-NP	O
%	%	NN	I-NP	O
TP	TP	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
76010036	76010036	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
METRONIDAZOLE	METRONIDAZOLE	NNP	I-NP	O
,	,	,	O	O
TOPICAL	TOPICAL	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
MASEY	MASEY	NNP	B-NP	O
,	,	,	O	O
LUKE	LUKE	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
68642497	68642497	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TRAMADOL	TRAMADOL	NN	I-NP	O
75	75	CD	I-NP	O
GM	GM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
GEROSA	GEROSA	NNP	B-NP	O
,	,	,	O	O
CLARENCE	CLARENCE	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CELEXA	CELEXA	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
54319651	54319651	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
HYDROBROMIDE	HYDROBROMIDE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
TRAMADOL	TRAMADOL	NN	I-NP	O
150	150	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
2pm	2pm	NN	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
DEUMAN	DEUMAN	NN	B-NP	O
,	,	,	O	O
STAN	STAN	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CELEXA	CELEXA	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
54319651	54319651	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
HYDROBROMIDE	HYDROBROMIDE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
TRAMADOL	TRAMADOL	NN	I-NP	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
ARIS	ARIS	NNP	B-NP	O
,	,	,	O	O
LEONARD	LEONARD	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CELEXA	CELEXA	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
54319651	54319651	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
HYDROBROMIDE	HYDROBROMIDE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
TORSEMIDE	TORSEMIDE	NN	I-NP	O
80	80	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/25	8/25	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
CELEXA	CELEXA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
WHITEBREAD	WHITEBREAD	NNP	B-NP	O
,	,	,	O	O
SCOTTY	SCOTTY	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
HYDROBROMIDE	HYDROBROMIDE	NN	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
HYDROBROMIDE	HYDROBROMIDE	NN	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
HYDROBROMIDE	HYDROBROMIDE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NNP	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
SEREVENT	SEREVENT	NNP	I-NP	O
DISKUS	DISKUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
DISKUS	DISKUS	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
BID	BID	NN	I-NP	O
POLLYSACCHARIDE	POLLYSACCHARIDE	NN	I-NP	O
IRON	IRON	NN	I-NP	O
150	150	CD	B-NP	O
%	%	NN	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Geddings	Geddings	NNP	I-NP	O
1wk	1wk	CD	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
2/12/04	2/12/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Surman	Surman	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Congestive	Congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Morbid	Morbid	NNP	I-NP	O
Obesitiy	Obesitiy	NNP	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrilation	fibrilation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
copd	copd	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Electrocardiogram	Electrocardiogram	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
X-ray	X-ray	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
64M	64M	NN	B-NP	O
c	c	NN	I-NP	O
CHF	CHF	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
and	and	CC	O	O
sequelae	sequelae	VB	B-VP	O
p/w	p/w	NN	B-NP	O
gradual	gradual	JJ	I-NP	O
increasing	increase	VBG	I-NP	O
SOB	SOB	NN	I-NP	B-protein
and	and	CC	I-NP	O
malaise	malaise	NN	I-NP	O
times	time	NNS	I-NP	O
10d	10d	CD	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
dx	dx	NN	I-NP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
empyema	empyema	NN	B-NP	O
,	,	,	O	O
A-fib	A-fib	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
he	he	PRP	B-NP	O
uses	use	VBZ	B-VP	O
2L	2L	NN	B-NP	O
of	of	IN	B-PP	O
O2	O2	NN	B-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	I-NP	O
CPAP	CPAP	NN	I-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
humid	humid	JJ	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
normally	normally	RB	B-ADVP	O
has	have	VBZ	B-VP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
~	~	NN	B-NP	O
10d	10d	CD	I-NP	O
ago	ago	IN	B-ADVP	O
the	the	DT	B-NP	O
humidity	humidity	NN	I-NP	B-protein
precipitated	precipitated	JJ	I-NP	I-protein
SOB	SOB	NN	I-NP	I-protein
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
increased	increase	VBN	B-NP	O
wheezing	wheezing	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
occasional	occasional	JJ	I-NP	O
cough	cough	NN	I-NP	O
and	and	CC	O	O
brown	brown	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
production	production	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
azithromycin	azithromycin	NN	B-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
that	that	WDT	B-NP	O
helped	help	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
LEE	LEE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
usu	usu	NN	I-NP	O
sx	sx	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
exas	exa	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
f/c	f/c	NN	B-NP	O
,	,	,	O	O
n/v	n/v	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
reports	report	NNS	I-NP	O
increasing	increase	VBG	B-VP	O
incontinence	incontinence	NN	B-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
CP	CP	NN	I-NP	B-DNA
Admission	Admission	NNP	I-NP	O
Data	Data	NNP	I-NP	O
:	:	:	O	O
VS	VS	NNP	B-NP	O
96.6	96.6	CD	B-NP	O
60120/67	60120/67	CD	I-NP	O
94	94	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3LNC	3LNC	NN	B-NP	O
NAD	NAD	NN	I-NP	O
,	,	,	O	O
A	A	NNP	B-NP	O
&	&	CC	I-NP	O
O	O	NNP	I-NP	O
Irreg	Irreg	NNP	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
M	M	NN	I-NP	O
rad	rad	NN	I-NP	O
to	to	TO	B-PP	O
axilla	axilla	NN	B-NP	O
LUNGS	LUNGS	NN	I-NP	O
:	:	:	O	O
distant	distant	JJ	B-NP	O
occas	occas	JJ	I-NP	O
dep	dep	NN	I-NP	O
crackles	crackle	NNS	I-NP	O
ABD	ABD	NNP	I-NP	O
Obese	Obese	NNP	I-NP	O
,	,	,	O	O
NTND	NTND	NNP	B-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
dependent	dependent	JJ	I-NP	O
Edema	Edema	NNP	I-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
chronic	chronic	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Warmth	Warmth	NNP	B-NP	O
R	R	NNP	I-NP	O
>	>	NNP	I-NP	O
L	L	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
slightly	slightly	RB	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
ruptured	rupture	VBD	B-VP	O
blister	blister	NN	B-NP	O
of	of	IN	B-PP	O
R	R	NN	B-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
,	,	,	O	O
healing	heal	VBG	B-VP	O
wound	wound	NN	B-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	O
2nd	2nd	NN	I-NP	O
toe	toe	NN	I-NP	O
,	,	,	O	O
healing	heal	VBG	B-VP	O
lesions	lesion	NNS	B-NP	O
at	at	IN	B-PP	O
L	L	NN	B-NP	O
upper	upper	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
:	:	:	O	O
BNP	BNP	NN	B-NP	B-protein
204	204	CD	I-NP	I-protein
,	,	,	O	O
TNI	TNI	NN	B-NP	B-protein
<	<	SYM	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
Ddimer	Ddimer	NN	B-NP	O
568	568	CD	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
2.3	2.3	CD	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
6.8	6.8	CD	I-NP	O
Assessment	Assessment	NNP	I-NP	O
:	:	:	O	O
64M	64M	NN	B-NP	O
c	c	NN	I-NP	O
morbid	morbid	NN	I-NP	O
obesity	obesity	NN	I-NP	O
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
from	from	IN	B-PP	O
mild	mild	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
vs	vs	IN	B-PP	O
COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

--	--	:	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
--	--	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
Pump	Pump	NN	B-NP	O
:	:	:	O	O
CXR/PE	CXR/PE	NN	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
interpret	interpret	VB	I-VP	O
given	give	VBN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
exacerbated	exacerbate	VBN	I-VP	O
2/2	2/2	CD	B-NP	O
concurrent	concurrent	JJ	I-NP	O
URI/COPD	URI/COPD	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
dependent	dependent	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
torsemide	torsemide	NN	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
2L	2L	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
noted	note	VBD	B-VP	O
improved	improved	JJ	B-NP	O
ease	ease	NN	I-NP	O
of	of	IN	B-PP	O
breathing	breathing	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
torsemide	torsemide	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
80mg	80mg	CD	B-NP	O
BID	BID	NNP	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
f/u	f/u	VB	I-VP	O
for	for	IN	B-PP	O
repeat	repeat	NN	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
A-Fib	A-Fib	NN	B-NP	B-protein
,	,	,	O	O
cont	cont	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
Ischemia	Ischemia	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
enzymes	enzyme	NNS	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
possible	possible	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
exas	exa	NNS	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
and	and	CC	O	O
only	only	RB	B-NP	O
recently	recently	RB	I-NP	O
dx	dx	NN	I-NP	O
c	c	NN	I-NP	O
asthma	asthma	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
cont	cont	VB	I-VP	O
treatment	treatment	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
with	with	IN	B-PP	O
short	short	JJ	B-NP	O
course	course	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

q6nebs	q6neb	NNS	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Doxycycline	Doxycycline	NN	B-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
given	give	VBN	B-VP	O
recent	recent	JJ	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
and	and	CC	I-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
coumadin	coumadin	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
felt	feel	VBD	B-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
Pneumonia	Pneumonia	NN	B-NP	O
unlikely	unlikely	JJ	I-NP	O
possible	possible	JJ	I-NP	O
PNA	PNA	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
infiltrates	infiltrate	NNS	I-NP	O
on	on	IN	B-PP	O
portable	portable	JJ	B-NP	O
CXR	CXR	NN	I-NP	B-protein
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PPX	PPX	NN	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
appt	appt	VBN	I-VP	O
for	for	IN	B-PP	O
bariatric	bariatric	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
in	in	IN	B-PP	O
Gu	Gu	NNP	B-NP	O
Osno	Osno	NNP	I-NP	O
Rock	Rock	NNP	I-NP	O
on	on	IN	B-PP	O
2/17	2/17	CD	B-NP	O
FULL	FULL	NN	I-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Riedel	Riedel	NNP	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
for	for	IN	B-PP	O
rechecking	rechecking	NN	B-NP	O
of	of	IN	B-PP	O
electrolytes	electrolyte	NNS	B-NP	O
with	with	IN	B-PP	O
new	new	JJ	B-NP	O
torsemide	torsemide	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

PLease	PLease	NN	B-NP	O
taper	taper	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
as	as	IN	B-PP	O
instructed	instruct	VBN	B-NP	O
Please	Please	NN	I-NP	B-protein
take	take	VBP	B-VP	O
doxycycline	doxycycline	NN	B-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Followup	Followup	NN	B-NP	O
c	c	NN	I-NP	O
PCP	PCP	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
for	for	IN	B-PP	O
electrolytes	electrolyte	NNS	B-NP	O
Echocardiogram	Echocardiogram	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
to	to	TO	B-PP	O
eval	eval	NN	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
function	function	NN	I-NP	O
Steroid	Steroid	NN	I-NP	O
taper	taper	NN	I-NP	O
Doxycycline	Doxycycline	NN	I-NP	O
for	for	IN	B-PP	O
7days	7day	NNS	B-NP	O
Increase	Increase	VBP	B-VP	O
torsemide	torsemide	NN	B-NP	O
to	to	TO	B-VP	O
80BID	80BID	NN	I-VP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BURGOS	BURGOS	NNP	B-NP	O
,	,	,	O	O
CLEVELAND	CLEVELAND	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OJ43	OJ43	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/21/04	1/21/04	CD	I-NP	O
@	@	SYM	B-NP	O
01	01	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

